![GORE VIABAHN Endoprosthesis](/sites/default/files/styles/max_750x750/public/2018-10/large.jpg.webp?itok=YasDBt6Q)
GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface*
Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface* enables you to deliver high patency and durable outcomes to minimize interventions for your patients.
![durable clinical study outcomes in complex cases](/sites/default/files/styles/max_750x750/public/2021-04/2180837-EN-VSX-02-Durable-FNL.png.webp?itok=7m672gdT)
![proven to significantly reduce reinterventions](/sites/default/files/styles/max_750x750/public/2021-04/2180837-EN-VSX-03-Reduce-FNL.png.webp?itok=33EQ0stg)
![high patency even in the most challenging disease](/sites/default/files/styles/max_750x750/public/2021-04/2180837-EN-VSX-04-Patency-FNL.png.webp?itok=prwHxM93)
![A leader among stent grafts with multiple indications for maximum versatility](/sites/default/files/styles/max_750x750/public/2021-04/2180837-EN-VSX-05-Leader-FNL.png.webp?itok=UAulYRnl)
![unparalleled performance through decades of partnership with clinicians across the globe](/sites/default/files/styles/max_750x750/public/2021-04/2180837-EN-VSX-06-Performance-FNL.png.webp?itok=twgSBm_k)
![viabahn stats](/sites/default/files/styles/max_750x750/public/2022-08/viabahn-stats-graphic.jpg.webp?itok=IVYlmvNE)
Performance evolution through collaboration
The GORE® VIABAHN® Device is a leader among stent grafts. Decades of partnership with clinicians around the globe has resulted in unparalleled performance across multiple indications. The GORE® VIABAHN® Device features:
- Lengths up to 25 cm
- Low profile design
- Radiopaque markers
- Proven CBAS® Heparin Surface technologyǂ
* As used by Gore, Propaten Bioactive Surface refers to Gore’s proprietary CBAS® Heparin Surface
† Data shown is representative of all generations of the device
ǂ CBAS® Heparin Surface. W. L. Gore & Associates Web site. https://goremedical.com/cbas/references. Accessed July 30, 2018.
† Data shown is representative of all generations of the device
ǂ CBAS® Heparin Surface. W. L. Gore & Associates Web site. https://goremedical.com/cbas/references. Accessed July 30, 2018.
For the approved indications of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface see Instructions for Use. Products are CE-certified under Regulation (EU) 2017/745 (hereinafter the “MDR”). But please note that the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface that have already been placed on the market before do not require re-certification, as the MDR provides for an extended transition period (Article 120 of the MDR). Those products were marketed under a valid CE-certification under EU directive 93/42/EEC and can be used further in accordance with the label, either until product expiration or May 2025.
231310350-EN